Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 8,873 | 11,829 | 13,333 | 13,007 | 5,049 |
| Cost of Goods | 641 | 3,153 | 1,072 | 583 | 86 |
| Gross Profit | 8,232 | 8,676 | 12,261 | 12,424 | 4,963 |
| Operating Expenses | 30,726 | 27,176 | 27,818 | 30,477 | 32,994 |
| Operating Income | -21,853 | -18,347 | -15,485 | -17,470 | -27,945 |
| Interest Expense | 35 | 34 | 0 | 0 | 0 |
| Other Income | 629 | 741 | 605 | 611 | 534 |
| Pre-tax Income | -21,260 | -17,641 | -14,880 | -16,860 | -27,411 |
| Income Tax | 34 | 39 | 9 | -19 | -4 |
| Net Income Continuous | -21,294 | -17,680 | -14,889 | -16,841 | -27,407 |
| Net Income | $-21,294 | $-17,680 | $-14,889 | $-16,841 | $-27,407 |
| EPS Basic Total Ops | -0.45 | -0.34 | -0.34 | -0.42 | -0.73 |
| EPS Basic Continuous Ops | -0.45 | -0.33 | -0.34 | -0.42 | -0.73 |
| EPS Diluted Total Ops | -0.45 | -0.34 | -0.34 | -0.42 | -0.73 |
| EPS Diluted Continuous Ops | -0.45 | -0.33 | -0.34 | -0.42 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.38 | -0.34 | -0.42 | -0.73 |
| EBITDA(a) | $-21,939 | $-18,676 | $-15,685 | $-17,771 | $-28,018 |